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Abstract
Background: Circadian rhythms govern a large array of physiological and metabolic functions. To achieve plasticity in
circadian regulation, proteins constituting the molecular clock machinery undergo various post-translational modifications
(PTMs), which influence their activity and intracellular localization. The core clock protein BMAL1 undergoes several PTMs.
Here we report that the Akt-GSK3b signaling pathway regulates BMAL1 protein stability and activity.
Principal Findings: GSK3b phosphorylates BMAL1 specifically on Ser 17 and Thr 21 and primes it for ubiquitylation. In the
absence of GSK3b-mediated phosphorylation, BMAL1 becomes stabilized and BMAL1 dependent circadian gene expression
is dampened. Dopamine D2 receptor mediated signaling, known to control the Akt-GSK3b pathway, influences BMAL1
stability and in vivo circadian gene expression in striatal neurons.
Conclusions: These findings uncover a previously unknown mechanism of circadian clock control. The GSK3b kinase
phosphorylates BMAL1, an event that controls the stability of the protein and the amplitude of circadian oscillation. BMAL1
phosphorylation appears to be an important regulatory step in maintaining the robustness of the circadian clock.
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Introduction
Circadian (from the Latin circa diem meaning ‘‘about a day’’)
rhythms occur with a periodicity of about 24 hours and enable
organisms to adapt and anticipate environmental changes.
Circadian control provides an evolutionary advantage to organ-
isms in adapting their behavior and physiology to the appropriate
time of day [1,2]. Feeding behavior, sleep-wake cycles, hormonal
levels and body temperature are just a few examples of
physiological circadian rhythms.
From a molecular standpoint, circadian rhythms are regulated by
transcriptional and post-translational feedback loops generated by
a set of interplaying clock proteins. The positive limb of the
mammalian clock machineryis comprised of CLOCK and BMAL1,
which are transcription factors that heterodimerize through the PAS
domain and induce the expression of clock-controlled genes by
binding to their promoters at E-boxes. Cryptochromes (Cry 1, Cry2)
and Period genes (Per1, Per2, Per3) are clock-controlled genes that
encode proteins that form the negative limb of the circadian
machinery. PER and CRY proteins are classically thought to
translocate into the nucleus to inhibit CLOCK:BMAL1 mediated
transcription, thereby closing the negative feedback loop [1].
Various core clock proteins undergo post-translational modifi-
cations (PTMs), a feature that is likely to contribute significantly to
the plasticity of the circadian system. PTMs have been shown to
regulate distinct functions, including transcriptional activation and
intracellular localization. PTMs have been proposed to participate
in controlling the timing between the activation and the repression
of circadian transcription [3]. Among the clock proteins, BMAL1
undergoes an extensive repertoire of PTMs, including phosphor-
ylation [4,5,6], acetylation [7], sumoylation [8,9] and ubiquityla-
tion [10]. Yet, the signaling pathways controlling the stability of
the BMAL1 protein have not been deciphered. In the present
study we have identified GSK3b as a critical regulator of BMAL1
stability and activity. GSK3b is a ubiquitous kinase which
regulates various cellular functions, ranging from glucose homeo-
stasis, to cell survival and cell-fate specification [11]. GSK3b has
been linked to various pathological conditions such as diabetes,
Alzheimer’s, cancer and bipolar disorder [12,13,14,15].
The role of GSK3b in circadian control has been reported. The
first evidence was based on the observation that shaggy (sgg), the
Drosophila ortholog of GSK3, controls the period of circadian
locomotor activity by phosphorylating TIMELESS and regulating
nuclear translocation of the PERIOD/TIMELESS heterodimer
[16,17]. Recently a high-throughput approach demonstrated that
inhibition of GSK3b leads to shortening of the period in cultured
mammalian cells [18]. In mammals, GSK3b has been reported
to phosphorylate PER2, CRY2 and Rev-erba. It has also been
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mammalian clock, suprachiasmatic nucleus (SCN) and in the
peripheral clocks (liver and fibroblasts) [19]. GSK3b mediated
phosphorylation appears to have differential effect on the stability
of the targeted substrates, since it has been shown to induce the
degradation of CRY2 [20] and the stabilization of Rev-erba [21].
Here we show that GSK3b specifically phosphorylates BMAL1
and primes it for ubiquitylation, followed by proteasomal
degradation. This control mechanism significantly influences the
efficacy and amplitude of circadian gene expression.
Results
GSK3b Phosphorylates BMAL1 and Primes It for
Ubiquitylation
BMAL1 is a phosphoprotein targeted by various kinases [4,5,6].
We noted that BMAL1 contains 15 sites with the consensus T/
SXXXS/T phosphoacceptor sequence for GSK3b. This prompt-
ed us to determine whether GSK3b can phosphorylate BMAL1.
We performed in vitro kinase assays on bacterially purified GST-
BMAL1 or GST alone by incubating them with recombinant
GSK3b in presence of c
32P-ATP. Our results demonstrate that
GST-BMAL1 was readily phosphorylated by GSK3b, whereas
GST alone, although expressed at much greater levels, was not
phosphorylated under equivalent conditions (Fig. 1A). Thus,
BMAL1 appears to be an efficient substrate of GSK3b.
Furthermore, to detect physical association between BMAL1
and GSK3b, HEK 293 cells were transiently transfected with
plasmids expressing BMAL1 and CLOCK in the presence or
absence of GSK3b. Immunoprecipitation of BMAL1, either in
presence or absence of CLOCK, pulled down GSK3b, confirming
that BMAL1 and GSK3b do interact physically (Fig. 1B).
Control of clock protein stability is a key regulatory step to
insure the tightness of circadian rhythms [22,23]. Moreover, it has
been shown that GSK3b-mediated phosphorylation of b-catenin,
SRC-3, and Smad3 leads to ubiquitylation followed by proteoso-
mal degradation [24,25,26]. Hence, we addressed the question of
whether GSK3b affects BMAL1 ubiquitylation. We co-expressed
HIS-tagged ubiquitin along with Myc-CLOCK and Flag-Myc-
BMAL1 with or without constitutively active (CA, Ser9.Ala
mutation) or kinase dead (KD, Lys85.Ala) mutants of HA-tagged
GSK3b. Ubiquitylated proteins were pulled down using Ni-
Sepharose beads under denaturing conditions and resolved by
SDS-PAGE. Upon Western analysis using anti-Flag antibody to
specifically detect BMAL1, we observed that co-expression of CA-
GSK3b greatly enhanced BMAL1 ubiquitylation, whereas
co-expression of KD-GSK3b had no effect on basal BMAL1
ubiquitylation (Fig. 1C). This result confirmed that phosphoryl-
Figure 1. GSK3b phosphorylates BMAL1 and primes it for ubiquitylation. (A) In vitro Kinase assay. Bacterially purified GST and GST-BMAL1
were incubated with recombinant GSK3b in presence of c
32P-ATP. Top panel shows the autoradiogram; bottom panel shows the coomassie blue
staining for the same gel. (B) HEK 293 cells were transfected with plasmids expressing Flag-myc-BMAL1, myc-CLOCK with or without HA-GSK3b. Total
lysates were prepared and subjected to immunoprecipitation using anti-BMAL1 antibody. Immunoprecipitated proteins were detected by Western
blotting (WB) using indicated antibodies. (C) Ubiquitylation assay. HEK 293 cells were transfected with plasmids expressing HIS-Ubiquitin, Flag-myc-
BMAL1, myc-CLOCK, with or without the constitutively active (CA) or kinase dead (KD) mutants of HA- tagged GSK3b. Ubiquitylated BMAL1 was
detected by Western analysis using anti-Flag antibody. Input samples were probed with anti-Flag (to detect BMAL1) and anti-GSK3b antibodies.
doi:10.1371/journal.pone.0008561.g001
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phosphorylation by GSK3b appears to be an important step in
BMAL1 proteosomal degradation, controlling BMAL1 cyclic
protein levels.
Inhibition of GSK3b Activity Enhances BMAL1 Stability
To further prove that phosphorylation by GSK3b affects
BMAL1 stability, we sought to inhibit GSK3b activity. Activation
of the Akt kinase results in phosphorylation and consequent
inactivation of GSK3b [27]. We transiently co-expressed BMAL1
and CLOCK, in presence or absence of a myristoylated form of
Akt that turns this kinase in a constitutively active status (CA-Akt).
Western analyses confirmed that co-expression of CA-Akt indeed
caused an increase in phosphorylation of GSK3b and its
consequent inactivation (Fig. 2A). Interestingly, expression levels
of BMAL1, but not CLOCK, was highly induced in cells that also
expressed CA-Akt (Fig. 2A). These results support the notion that
phosphorylation by GSK3b might lead to BMAL1 degradation.
To further substantiate our hypothesis, we ectopically expressed
BMAL1 in mouse embryo fibroblasts (MEFs) derived from WT or
GSK3b
2/2 mice. Myc-tagged GFP was co-expressed as a control.
We observed that BMAL1 levels were much higher in GSK3b
2/2
MEFs as compared to WT MEFs (Fig. 2B). GFP levels were
similar in both cell lines. These results demonstrate that there is
significantly higher accumulation of BMAL1 in the absence of
GSK3b. Next, we sought to rescue the GSK3b
2/2 MEFs by
re-introducing GSK3b. BMAL1 was ectopically expressed by
transient transfection into WT and GSK3b
2/2 MEFs, in
conjunction or not of a HA-tagged GSK3b. Rescue of GSK3b
function in the GSK3b
2/2 MEFs caused a decrease in BMAL1
protein levels which returned to those in WT MEFs (Fig. 2C).
To determine whether the half-life of the endogenous BMAL1
protein depends on GSK3b, we treated WT and GSK3b
2/2
MEFs with cycloheximide to block protein synthesis. Importantly,
both BMAL1 basal protein levels and its stability are much higher
in the absence of GSK3b (Fig. 2D). These results show that
phosphorylation of BMAL1 by GSK3b regulates its stability.
S17 and T21 on BMAL1 Are Targets for GSK3b Mediated
Phosphorylation
Among the 15 consensus GSK3b sites on BMAL1, we focused
our attention on two loci which contained multiple GSK3b
consensus sites in tandem. These sites included a region between
residues 9 and 25, and another between residues 233 and 241 which
are highly conserved in vertebrates (Fig. 3A,B). Importantly, both
loci contain a motif which fits a highly stringent consensus for
GSK3b mediated phosphorylation [S/TPXXS/T]. Thus, S17 and
T21 at the first locus, and T233 and S237 at the second locus,
appear to be privileged candidates for phosphorylation by GSK3b.
In order to determine if any of these sites are bona fide targets for
GSK3b, we first analyzed the effect of point mutations at these sites
on BMAL1 phosphorylation. We generated a panel of Ser.Ala
mutants including: (i) S17 and T21 (S17,T21/A), (ii) T233, S237
and S241 (T233,S237,S241/A), and (iii) S17, T21, T233, S237 and
S241 (S17,T21,T233,S237,S241/A). Plasmids expressing either
wild type or BMAL1 mutants were co-transfected in HEK 293 cells
along with a plasmid expressing Myc-CLOCK and harvested
48 hours post-transfection. Although phosphorylation was reduced
Figure 2. GSK3b regulates BMAL1 stability. (A) HEK 293 cells were co-transfected with plasmids expressing Flag-myc-BMAL1, myc-CLOCK with
or without CA-Akt. 48 hours post-transfection nuclear lysates were prepared and resolved by SDS-PAGE. CLOCK and BMAL1 levels were detected by
Western analysis using anti-Myc antibody; phospho- and total GSK3b and HSC70 (loading control) were detected by using specific antibodies. (B) WT
and GSK3b
2/2 MEFs were transfected with plasmids expressing Flag-myc-BMAL1, myc-CLOCK and myc-GFP. Nuclear lysates were resolved by SDS-
PAGE followed by Western analysis. BMAL1 and GFP levels were detected by anti-Myc antibody. Total GSK3b was detected using a specific antibody.
(C) Same as in (B) except that indicated lanes were also transfected with a plasmid expressing HA-tagged GSK3b. (D) WT and GSK3b
2/2 MEFs were
treated with 50 mg/ml Cycloheximide (CHX), total lysates were prepared at indicated times and resolved by SDS-PAGE. Endogenous BMAL1 and
GAPDH levels were detected by Western analysis using specific antibodies. Data shown is representative of three independent experiments.
doi:10.1371/journal.pone.0008561.g002
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in BMAL1 phosphorylation (Fig. 3C).
To prove that S17 and T21 are directly phosphorylated by
GSK3b, we performed an in vitro kinase assay with WT and mutant
forms of GST-BMAL1. We observed that GSK3b mediated
phosphorylation of BMAL1 was reduced when S17 and T21 were
mutated (Fig. 3D). This result shows that S17 and T21 are critical
sites of GSK3b-mediated phosphorylation, and indicates the
presence of yet unrecognized phosphoacceptor sites in the protein.
Interestingly, the importance of the S17,T21 sites is validated by the
higher, albeit modest, stability of the S17,T21A-BMAL1 mutated
protein as compared to the wild type BMAL1 (Fig. 3E,F).
Oscillation in GSK3b Activity Correlates with BMAL1
Levels
Our results show that GSK3b regulates BMAL1 levels. Thus,
we questioned whether BMAL1 oscillation would be influenced in
the absence of GSK3b. To address this question, we synchronized
WT and GSK3b
2/2 MEFs, and analyzed BMAL1 levels by
Western analysis. BMAL1 levels oscillate as expected in WT
MEFs, peaking at 6 to 12 hours post-synchronization with lowest
levels at 24 hours post-synchronization (Fig. 4A). BMAL1 levels in
GSK3b
2/2 MEFs display only a mild oscillation, with total levels
of the protein being much higher at all time points (Fig. 4A).
Importantly, the Bmal1 transcript levels and cyclic expression
profile were unchanged in the GSK3b
2/2 MEFs as compared to
WT cells (Fig. 4B). These results indicate that GSK3b is critical for
the circadian oscillation of BMAL1 protein. It is, however,
important to stress that the residual oscillation of BMAL1 in the
GSK3b
2/2 MEFs indicates the presence of other pathways which
may contribute to BMAL1 turnover. One pathway could implicate
GSK3a, a kinase structurally similar to GSK3b but not as
comprehensively studied.
Next we analyzed whether regulation of GSK3b activity by
phosphorylation may oscillate in a circadian manner. Using anti
phospho-GSK3b antibodies we reveal that there is more phosphor-
ylation of GSK3b (corresponding to decreased kinase activity) at 6 to
12 hours post synchronization of the MEFs (Fig. 4C). The peak of
GSK3b phosphorylation correlates with the increase in BMAL1
protein levels; vice versa, when GSK3b activity is high (24 to
30 hours post synchronization), BMAL1 levels are low (Fig. 4A,C).
Figure 3. GSK3b phosphorylates Ser 17 and Thr 21 on BMAL1. (A) Amino acid sequence around two putative GSK3b consensus sites on
mBMAL1. (B) Sequence alignment of the two putative GSK3b consensus sites on BMAL1 showing conservation across species. (C) HEK 293 were
transfected with plasmids expressing myc-CLOCK and WT or mutant Flag-myc-BMAL1. 48 hours post-transfection total lysates were prepared and
resolved by SDS-PAGE. BMAL1 and CLOCK levels were detected by anti-Myc antibody. Slower migrating phosphorylated BMAL1 band is indicated by
an arrow. (D) Bar graph representing phosphorylation levels of WT and S17,T21/A BMAL1 as analyzed by In vitro kinase assay (as in Fig. 1A). Data is
representative of three independent experiments. (E) WT or S17,T21/A mutant of Flag-myc-BMAL1, along with myc-GFP were transiently expressed in
JEG3 cells and treated with 50 mg/ml CHX. Total lysates were prepared at indicated times and resolved by SDS-PAGE. BMAL1 and GFP levels were
detected by Western analysis using anti-myc antibody. Data shown is representative of three independent experiments. (F) Line graph showing
quantitation of BMAL1 levels, normalized to GFP levels, from Fig. 3E.
doi:10.1371/journal.pone.0008561.g003
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we analyzed its phosphorylation in parallel with GSK3b (Fig. 4C).
GSK3a phosphorylation oscillates with a profile analogous to
GSK3b, an event that persisted in GSK3b
2/2 MEFs. This
observation may suggest that GSK3a could partially compensate
for the loss of GSK3b in circadian control, although more studies
are needed to confirm whether GSK3a plays a role in BMAL1
phosphorylation and turnover.
GSK3b
2/2 MEFs Display Dampened Circadian Oscillation
of Dbp mRNA
The regulation of BMAL1 phosphorylation and stability by
GSK3b may impact on the cyclic expression of clock-controlled
genes. We thereby compared the expression profile of the Dbp
gene in WT and GSK3b
2/2 MEFs synchronized by dexameth-
asone. Lack of GSK3b resulted in a significant dampening of Dbp
oscillation as compared to WT MEFs, featuring a conserved
period but decreased amplitude (Fig. 4D). These results support
the notion that stabilization of BMAL1 protein levels might lead to
reduction in its transcription activation ability [28].
Dopamine Signaling Regulates the Circadian Clock by
Controlling BMAL1 Turnover
Dopamine signaling via the D2 receptor (D2R) has been
demonstrated to modulate the Akt-GSK3b pathway in vivo [29]. In
addition, we have previously reported that CLOCK:BMAL1
transcriptional activity is enhanced by activation of D2R-mediated
signaling [30]. We thus used the D2R
2/2 mice [31] as a model to
analyze the effect of inactivating the GSK3b pathway in vivo.T o
do so, we isolated the striatum from brains of mice entrained at
different times of the circadian cycle (LD 12:12). While the cyclic
expression profile and mRNA levels of Bmal1 were similar in the
striatum from WT and D2R
2/2 animals (Fig. 5A), the levels of
BMAL1 protein were elevated in the D2R
2/2 mice (Fig. 5B). This
result parallels the inactivation of the GSK3b pathway observed in
cultured MEFs (Fig. 4). Also, consistent with the expression profile
observed in the GSK3b
2/2 MEFs, the amplitude of the circadian
expression of both Dbp and Per2 is significantly decreased in the
striatum of D2R
2/2 mice (Fig. 5C and D). These results confirm
that the GSK3b pathway regulates circadian gene expression by
controlling BMAL1 protein stability in vivo.
Discussion
BMAL1 is a critical regulator of the circadian clock. Its ablation
in the mouse, in addition to causing arrhythmicity [32], leads to
premature aging and reduced life-span [33]. BMAL1 is a crucial
player in the regulation of metabolism, playing a role in
adipogenesis [34] and in the control of glucose and triglycerides
levels [35]. Mice with a liver specific deletion of Bmal1 show
normal locomotor activity, but the circadian expression of key
Figure 4. Circadian defects in GSK3b
2/2 MEFs. WT and GSK3b
2/2 MEFs were synchronized by 2 hour treatment with 100nM dexamethasone
(DEX). (A) Total lysates were prepared at indicated times post synchronization and resolved by SDS-PAGE followed by Western analysis. BMAL1 and a-
tubulin levels were detected by specific antibodies. (B) RNA was prepared at indicated times, reverse transcribed, and real-time PCR was performed
using primers for Bmal1 and 18S rRNA. Data is represented as relative levels of Bmal1 normalized to 18S rRNA. (C) Same as in (A), except phospho-
GSK3a/b and total GSK3b levels were detected by specific antibodies. (D) RNA was prepared at indicated times, reverse transcribed, and real-time PCR
was performed using primers for Dbp and 18S rRNA. Data is represented as relative levels of Dbp normalized to 18S rRNA.
doi:10.1371/journal.pone.0008561.g004
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This results in mice being hypoglycemic during the fasting phase
of the feeding cycle [36].
The important roles played by BMAL1 parallel multiple levels
of regulation of its function. BMAL1 undergoes various PTMs,
including phosphorylation, acetylation [7], sumoylation [8,9] and
ubiquitylation [10]. While the functional interactions between
these PTMs have not been deciphered, phosphorylation by
distinct kinases appears to regulate unique activities [10,37].
Specifically, phosphorylation by Casein Kinase Ie (CKIe) has been
reported to activate BMAL1-mediated transcription [6], while
phosphorylation by MAPK inhibits it [4]. Recently we have shown
that CK2a-mediated phosphorylation regulates BMAL1 intracel-
lular localization [5]. Our present results indicate that GSK3b
activity is circadian and that BMAL1 phosphorylation by this
kinase controls its stability.
Our analysis identified S17 and T21 in BMAL1 as major target
sites for GSK3b- mediated phosphorylation. While mutation of
these residues leads to a reduction of phosphorylation and an
increase in BMAL1 stability, we predict the presence of additional
GSK3b phosphoacceptor sites on BMAL1. Importantly, multiple
phosphorylation events on a clock protein, presumably by multiple
kinases appear to be a common mode of regulation. For example,
it has been recently shown that the Neurospora clock protein
FREQUENCY is phosphorylated at 75 residues [38]. The
phosphorylation status of several of these residues changes
according to the time of the day and regulates period length. In
mammals, PER2 has been shown to be phosphorylated at 21 sites,
regulating its stability and localization [39]. While a detailed
proteomic analysis of BMAL1 phosphorylation is warranted, our
results reveal that GSK3b is pivotal in circadian function as it
controls the stability of a core clock regulator. Further illustrating
the importance of GSK3b in circadian regulation, a recent report
demonstrated that GSK3b can also phosphorylate CLOCK and
regulate its stability [40]. It would be interesting to explore
whether, similarly to what we describe here for dopamine (Fig. 5),
some specific pathways known to operate via GSK3b, such as the
insulin signaling in liver [15], regulate the circadian clock by
altering the phosphorylation state and the stability of BMAL1.
The implication of GSK3b in circadian control is significant,
especially considering that this kinase has been linked to various
diseases such as diabetes, Alzheimer’s, cancer and neuropsychiat-
ric disorders. The link between D2R signaling and BMAL1
stability is challenging, as dopamine dysfunctions underlie
neurological and psychiatric disorders which are disruptive of
the circadian clock. Future studies will determine whether
GSK3b-mediated disruption of normal circadian control is
causally linked to some of these pathological conditions. In this
sense, it is interesting that the activity of GSK3a also oscillates in
circadian manner (Fig. 4). Although our data suggests that GSK3a
might partially compensate for the loss of GSK3b, further studies
are needed to determine whether BMAL1 and other clock
components can be phosphorylated by GSK3a.
It could be argued that the effects of GSK3b on BMAL1 are
indirect. It has indeed been shown that phosphorylation of Rev-
erba by GSK3b leads to its stabilization [21]. Since Rev-erba is a
Figure 5. BMAL1 mRNA and protein levels in WT and D2R
2/2 mice. Mice entrained in 12 hr Light – 12 hr Dark cycles were sacrificed at
indicated times and their striatum was dissected out. (A) RNA was prepared at indicated times, reverse transcribed, and real-time PCR was performed
using primers for Bmal1 and 18S rRNA. Data is represented as relative levels of Bmal1 normalized to 18S rRNA. (B) Total lysates were prepared and
resolved by SDS-PAGE. BMAL1 and a-tubulin levels were detected by Western analysis using specific antibodies. (C,D) Same as in (A), except real-time
PCR was performed using primers for (C) Dbp and (D) Per2.
doi:10.1371/journal.pone.0008561.g005
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when GSK3b is inhibited, Rev-erba will be less stable, and hence,
Bmal1 transcription may be de-repressed. However, our results
conclusively demonstrate that the observed stabilization of
BMAL1 protein upon GSK3b inhibition is independent of Rev-
erba. The evidence in support of our argument is: (i) BMAL1
protein has a longer half-life in GSK3b
2/2 MEFs when compared
to WT MEFs (Fig. 2D); (ii) BMAL1 accumulation upon GSK3b
inhibition is evident not only on endogenous BMAL1, but also on
ectopically expressed BMAL1 (Fig. 2). The exogenous BMAL1 is
not under control of the Bmal1 promoter and hence can not be
affected by Rev-erba; and (iii) BMAL1 protein levels are higher in
the GSKb
2/2 MEFs and D2R
2/2 mice than in their wild type
counterparts, although Bmal1 circadian mRNA levels are virtually
equivalent (Figs. 4 A,B and 5 A,B). Altogether, the present findings
unequivocally show that phosphorylation of BMAL1 by GSK3b is
a critical step in the control of its stability.
Recent reports have indicated that although circadian locomo-
tor activity persists in mice displaying constitutively higher levels of
BMAL1, either due to abolished Rev-erba expression[41] or by
transgenic re-expression in Bmal1
2/2 mice [42], the period length
is rendered shorter. Moreover, robustness in tissue-specific
circadian expression of certain clock genes (e.g. Cry1, Dbp)i s
compromised in these animals. These observations are in
agreement with our data showing that increased BMAL1 protein
levels in GSKb
2/2 MEFs and D2R
2/2 mice does not abolish
circadian gene expression, but affects its amplitude.
PTMs are often found in specific combinations in order to
regulate protein activity [43]. Phosphorylation and ubiquitylation
are often found to be coupled. In certain cases, such as b-catenin,
IkBa, cyclin E, SREBP1, phosphorylation of a protein generates a
‘‘Phosphodegron’’ which promotes recognition by ubiquitin ligases
[43]. Interestingly, in case of some transcription factors, their
transcriptional activation domains (TAD) and degrons are
overlapping [28]. The ‘‘Black Widow’’ model for transcription
activation suggests that certain transcription factors are active only
when unstable and their ubiquitylation status positively correlates
with their activity. For example, stabilization of VP16 TAD causes
its inactivation [44]. The VP16 TAD signals its ubiquitylation
through the Met30 ubiquitin ligase. In the absence of Met30,
VP16 is more stable but is unable to activate transcription. For
BMAL1, it is notable that at specific times of the day when its
abundance is low, its activity is high [45]. The low abundance of
BMAL1 also coincides with its high phosphorylation. Thus, we
speculate that activation by BMAL1 also follows the ‘‘Black
Widow’’ model: upon GSK3b mediated phosphorylation and
generation of phosphodegrons, ubiquitylation by yet uncharacter-
ized ubiquitin ligases would de-stabilize and thus, activate
BMAL1. Identification of the E3 ubiquitin ligase specific for
BMAL1, and the sites for ubiquitylation on BMAL1 should be the
subject of future studies that would provide invaluable information
on the control of circadian rhythms.
Materials and Methods
Animals
Generation of D2R-deficient mice has been described [31]. The
D2R-null mice and wild type mice used were littermates. Mice
housed in individual cages were entrained on a L12:D12 (12 h light–
12 h dark) cyclefor two weeks before analyses. Micewere sacrificed at
specified circadian times and striata were isolated and homogenized
as described (27). All research involving vertebrate animals has been
performed under protocol approved by the Institutional Animal Care
and Use Committee (IACUC). Animals are monitored on a daily
basis by both the lab and University Lab Animal Resources (ULAR)
veterinary staff for signs of distress, pain, and/or infection, and are
given ad libitum access to food and water. Cages were cleaned on a
weekly basisand when visiblysoiled to maintaina clean environment.
All husbandry procedures and welfare policies are conducted
according to the Guide for the Care and Use of Laboratory Animals,
set forth by the Institute of Laboratory Animal Resources,
Commission on Life Sciences, and National Research Council.
Reagents
Plasmid expressing a myristoylated form of AKT (constitutively
active) was from Millipore (Temecula, CA). Plasmids expressing
wild type, constitutively active or kinase dead forms of GSK3b
were gifts from Dr. Jim Woodgett (Samuel Lunenfeld Research
Institute, Mount Sinai Hospital, Toronto, Canada). Myc-tagged
Clock, Flag-Myc- tagged Bmal1, and Myc-tagged GFP plasmids
have been described earlier [7]. Antibodies against phospho-
GSK3a/b were from Cell Signaling Technology (Danvers, MA);
anti-Myc and anti-GAPDH from Millipore (Temecula, CA); anti-
flag and anti-tubulin from Sigma (St. Louis, MO); anti-HSC70
from Santa Cruz Biotechnology, Inc (Santa Cruz, CA); and anti-
total GSK3b was from BD Biosciences (San Jose, CA). Site
directed mutagenesis kit was from Stratagene (La Jolla, CA).
Cell Culture and Transfection
HEK 293 cells (ATCC, Manassas, VA) were cultured in
DMEM supplemented with 10% NCS and antibiotics. JEG3 cells
(ATCC, Manassas, VA) were cultured in BME supplemented with
10% FBS and antibiotics. Cells were transfected with indicated
plasmids using BioT transfection reagent (Bioland Scientific LLC,
Cerritos, CA) according to manufacturer’s recommendations.
Mouse embryonic fibroblasts (MEFs) were cultured in DMEM
supplemented with 10% FBS and antibiotics. Confluent MEFs
were synchronized by treatment with 100nM Dexamethasone
(Sigma, St. Louis, MO) for 2 hours. Wild type and GSK3b
2/2
MEFs were generous gifts from Dr. Jim Woodgett.
Preparation of Total and Nuclear Extracts from Cultured
Cells
Cells were washed twice with cold phosphate buffered saline
(PBS) and lysed in RIPA buffer (50 mM Tris pH 8.0, 150 mM
NaCl, 5 mM EDTA, 15 mM MgCl2, 1% NP40, 16 protease
inhibitor cocktail (Roche Diagnostics, Indianapolis, IN ), 1mM
DTT, 10 mM NaF, 1 mM PMSF). For nuclear extracts, after
washing cells with cold PBS, cells were lysed with hypotonic buffer
(10 mM HEPES-KOH pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 16
protease inhibitor cocktail, 1mM DTT, 10 mM NaF, 1 mM
PMSF). Following a brief centrifugation, pellet was resuspended in
hypertonic buffer (20 mM HEPES-KOH pH 7.9, 25% glycerol,
420 mM NaCl, 1.5mM MgCl2, 0.2 mM EDTA, 16 protease
inhibitor cocktail, 1mM DTT, 10 mM NaF, 1 mM PMSF).
Supernatants were recovered as nuclear extracts.
Ubiquitylation Analysis
HEK 293 cells were co-tranfected with plasmids expressing
HIS-tagged ubiquitin, Myc-Clock, flag-Myc-Bmal1 and constitu-
tively active (CA) or kinase dead (KD) mutants of HA-tagged
GSK3b. 48 hours post-transfection, cells were treated with 10 mM
MG132 for 6 hours, and then lysed in denaturing buffer
containing 8 M Urea. Ubiquitylated (and thus HIS tagged)
proteins were enriched with Ni–sepharose 6 fast flow beads (GE
healthcare, Uppsala, Sweden) and ubiquitylated BMAL1 was
detected by Western analysis with the antibody against Flag.
BMAL1 and GSK3b
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Glutathione-S-transferase (GST) or GST-BMAL1 proteins were
purified from BL21 strain of Escherichia coli using glutathione-
sepharose beads (GE Healthcare, Uppsala, Sweden). Purified
proteins were washed in kinase buffer (20mM Tris-HCl, pH 7.5,
10mM MgCl2, 5mM DTT) and then incubated with or without
25 ng recombinant GSK-3b (New England Biolabs, Ipswich, MA)
in presence of 200 mM ATP and 5 mCi c
32p ATP at 30uC for
30 min. Reaction was terminated by boiling in presence of
Laemmli buffer. Samples were resolved by SDS-PAGE, stained by
Coomassie blue, destained, dried and then phosphorylated
BMAL1 was detected by autoradiography.
Quantitative Real-Time RT-PCR
Each quantitative real-time RT-PCR was performed using the
Chromo4 real time detection system (BIO-RAD). The PCR
primers for mBmal1 mRNA, mDbp mRNA, mPer2 mRNA, 18S
rRNA are available upon request. For a 20 ml PCR, 50 ng of
cDNA template was mixed with the primers to final concentra-
tions of 200 nM and 10 ml of iQ SYBR Green Supermix (BIO-
RAD), respectively. The reaction was first incubated at 95uC for
3 min, followed by 40 cycles at 95uC for 30 s and 60uC for 1 min.
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